Comparing Internet Blood Glucose Monitoring System and Continuous Glucose Monitoring System
Type 2 Diabetes Mellitus
About this trial
This is an interventional supportive care trial for Type 2 Diabetes Mellitus focused on measuring Remote Blood Glucose Monitoring System,, Continuous Glucose Monitoring System,, Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria:
- Type 2 diabetes patients being treated with insulin for at least 3 months
- HbA1c > 7%
- > 25 years of age
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be trained on using the Continuous Glucose Monitoring System
- Willingness to be randomized
- Trained in self-blood glucose monitoring
- Internet Access on a Windows Personal Computer
- No prior use or training on CGMS in the past 6 months
- No prior use or training on IBGMS in the past 6 months
Exclusion Criteria:
Patients who do not meet the above criteria or are not willing to participate will not be included in the study. Additional exclusion criteria include:
- Patient with medical conditions that may affect their study participation or results will be excluded.
- Patients with the potential to become pregnant
- Patients using medications known to influence control of diabetes (eg steroids systemic or inhaled)
- Liver disease (AST or ALT levels > 2.5 times the reference level)
- Renal insufficient with a serum creatinine level > 200 μmol/L
Sites / Locations
- St. Paul's Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Internet Intervention
Continuous Glucose Monitoring
The subjects enrolled in the Internet Therapeutic Intervention arm receive standard care by testing their blood glucose at least 3 times daily and visit the endocrinologist every 3 months; however, they are also asked to upload their blood glucose readings online every 2 weeks for the health practitioner to view and comment upon.
The use of CGMS (Sensor, receiver, transmitter) plus the uploading of results to the Internet-based software utility of CareLink Personal and generating reports that can be viewed and used at the patient's own preference. This group will send the uploaded data and receive feedback from their endocrinologist every 2 weeks.